- Motley Fool•10 months ago
It's been a tough year so far for the genomic sequencing leader's stock. Are better days ahead?
- Motley Fool•last year
Higher costs of revenue hurt the genomic sequencing company in the fourth quarter.
- Zacks•2 years ago
Gilead Sciences, Inc.'s (GILD) fourth-quarter earnings (including stock-based compensation expenses) of $2.38 per share.
AFFY : Summary for AFFYMAX INC COM STK USD0.001 - Yahoo Finance
Affymax, Inc. (AFFY)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.06 - 0.06|
|52 Week Range||0.05 - 0.10|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||0.71|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|